Table 3.
CHD (N=77) | CVD (N=117) | ACM (N=168) | ||||
---|---|---|---|---|---|---|
HR (95% CI) | Pvalue | HR (95% CI) | Pvalue | HR (95% CI) | Pvalue | |
Model 1 | ||||||
AAC density, per SD | 0.70 (0.26, 1.86) | 0.47 | 0.41 (0.16, 1.04) | 0.06 | 0.43 (0.19, 0.95) | 0.04* |
ln(AAC volume), per SD | 1.27 (1.10, 1.45) | < 0.01* | 1.34 (1.17, 1.53) | < 0.01* | 1.33 (1.19, 1.49) | < 0.01* |
Model 2 | ||||||
AAC density, per SD | 0.97 (0.34, 2.74) | 0.95 | 0.66 (0.24, 1.80) | 0.42 | 0.46 (0.20, 1.07) | 0.07 |
ln(AAC volume), per SD | 1.15 (1.002, 1.33) | 0.05 | 1.21 (1.06, 1.38) | < 0.01* | 1.30 (1.15, 1.48) | < 0.01* |
CAC density, per SD | 0.65 (0.33–1.26) | 0.20 | 0.47 (0.25–0.90) | 0.02 | 0.92 (0.56, 1.53) | 0.76 |
ln(CAC volume), per SD | 1.23 (1.08, 1.41) | < 0.01* | 1.25 (1.10, 1.41) | < 0.01* | 1.04 (0.94, 1.15) | 0.44 |
Model 3 - Adjusted for GFRS, ethnicity, and statin therapy |
||||||
AAC density, per SD | 1.07 (0.36, 3.14) | 0.90 | 0.93 (0.33, 2.57) | 0.89 | 0.57 (0.24, 1.35) | 0.20 |
ln(AAC volume), per SD | 1.10 (0.95, 1.28) | 0.20 | 1.14 (1.00, 1.32) | 0.06 | 1.25 (1.36, 1.42) | < 0.01* |
CAC density, per SD | 0.74 (0.38, 1.47) | 0.08 | 0.55 (0.29, 1.04) | 0.07 | 1.12 (0.66, 1.88) | 0.68 |
ln(CAC volume), per SD | 1.17 (1.04, 1.59) | 0.02* | 1.20 (1.05, 1.36) | < 0.01* | 0.99 (0.90, 1.10) | 0.91 |
CHD = myocardial infarction, resuscitated cardiac arrest, or CHD death. CVD = CHD plus non-fatal or fatal stroke.
Global Framingham risk score (GFRS, composite of age, sex, smoking and diabetes status, total and HDL cholesterol, systolic blood pressure and blood pressure treatment). Two-tailed p-value < 0.05 considered significant, ln = natural log.